Nicola Valeri

AstraZeneca (United Kingdom) — United Kingdom

Medicine · Health Sciences

44h-index10.7kcitations304works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(85), Cancer Genomics and Diagnostics(74), MicroRNA in disease regulation(65), Cancer-related molecular mechanisms research(59), Genetic factors in colorectal cancer(59)

Publications304 total

Supplementary Figure 7 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
2025Open Access
Supplementary Figure 11 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
2025Open Access
Supplementary Figure 10 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
2025Open Access
Supplementary Figure 2 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
2025Open Access
Supplementary Table 2 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
2025Open Access
Supplementary Figure 12 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
2025Open Access
Supplementary Figure 9 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
2025Open Access
Supplementary Table 1 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
2025Open Access
Supplementary Figure 4 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
2025Open Access
Supplementary Figure 3 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
2025Open Access
Supplementary Figure 6 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
2025Open Access
Supplementary Figure 5 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
2025Open Access
Supplementary Figure 13 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
2025Open Access
Supplementary Figure 1 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
2025Open Access
Supplementary Figure 14 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
2025Open Access
Supplementary Figure 15 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
2025Open Access
Supplementary Figure 8 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
2025Open Access
LBA81 Final overall survival (OS) and the association of pathological outcomes with event-free survival (EFS) in MATTERHORN: A randomised, phase III study of durvalumab (D) plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric / gastroesophageal junction (G / GEJ) adenocarcinoma
Annals of Oncology·2025· 3 cited
Figure 1 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
2025Open Access
Figure 7 from Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
2025Open Access
page 1 of 16Next →

Frequent Co-authors

Chiara Braconi(18), David Cunningham(17), Andrea Lampis(16), Matteo Fassan(16), Jens C. Hahne(15), Georgios Vlachogiannis(10), Ian Chau(10), Massimo Rugge(10), Ruwaida Begum(9), Naureen Starling(9), Andrew Wotherspoon(9), Carlo M. Croce(9), Sheela Rao(8), David Watkins(8), Somaieh Hedayat(7), Elizabeth Smyth(7), Owen J. Sansom(7), Pierluigi Gasparini(7), Khurum Khan(6), Muller Fabbri(6)